§ 13F · FUND PROFILE
Lynx1 Capital Management LP.
AUM · $491M (13F)Positions · 14Turnover · n/a · Q2Filed · Aug 13, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$2M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 13, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | GHRS | GH RESEARCH PLC | 13.26M | $357M | 26.0% | +23% |
| 2 | CGEM | CULLINAN THERAPEUTICS INC | 8.96M | $163M | 11.9% | — |
| 3 | STOK | STOKE THERAPEUTICS INC | 4.04M | $132M | 9.6% | +70% |
| 4 | AGIO | AGIOS PHARMACEUTICALS INC | 3.41M | $127M | 9.2% | +161% |
| 5 | CCCC | C4 THERAPEUTICS INC | 7.33M | $34M | 2.5% | — |
| 6 | KRRO | KORRO BIO INC | 1.54M | $20M | 1.5% | +100% |
| 7 | TCRX | TSCAN THERAPEUTICS INC | 8.02M | $8M | 0.6% | +100% |
| 8 | DTIL | PRECISION BIOSCIENCES INC | 950K | $7M | 0.5% | — |
| 9 | NEUP | NEUPHORIA THERAPEUTICS INC | 875K | $4M | 0.3% | — |
| 10 | PASG | PASSAGE BIO INC | 674K | $3M | 0.2% | +116% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE LYNX1 SIGNAL
AC read
Lynx1 Capital Management LP is a Other fund managing $491 million in assets. The fund runs a focused portfolio of just 14 positions.
Read the full dossier →